歐冠昇:中國債券市場存在重大機遇 本港具獨特中間人角色
港交所(00388.HK)行政總裁歐冠昇(Nicolas Aguzin)於債券通論壇上表示,在新型肺炎疫情過後,中國帶領環球經濟增長,加上在長期低息環境下,中國市場對投資者的吸引力增加。另外中國「碳中和」目標亦有助綠色人民幣債券市場發展。在有關情況下,本港繼續發揮獨特優勢,連接中國及國際資本市場,並擁有全球最大離岸人民幣資金池,有助中國及國際市場之間雙向資金流動,有關角色日益重要。
他指,債券通推出後相當成功,表現並超越預期,為國際投資者提供投資於中國全球第二大債券市場的渠道,現時債券通上提供產品較初推出時增加十倍。港交所將繼續推出更多交易產品及服務,過去四年債券通已奠定強大基礎,相信未來將產生更多資金流動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.